Suppr超能文献

在引入肺炎球菌结合疫苗的前一年,肯尼亚感染艾滋病毒的父母中肺炎链球菌定植率很高。

High Streptococcus pneumoniae colonization prevalence among HIV-infected Kenyan parents in the year before pneumococcal conjugate vaccine introduction.

作者信息

Conklin Laura M, Bigogo Godfrey, Jagero Geofrey, Hampton Lee, Junghae Muthoni, da Gloria Carvalho Maria, Pimenta Fabiana, Beall Bernard, Taylor Thomas, Plikaytis Brian, Laserson Kayla F, Vulule John, Van Beneden Chris, Whitney Cynthia G, Breiman Robert F, Feikin Daniel R

机构信息

Division of Bacterial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Respiratory Diseases Branch, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS C-25, Atlanta, GA, 30333, USA.

出版信息

BMC Infect Dis. 2016 Jan 16;16:18. doi: 10.1186/s12879-015-1312-2.

Abstract

BACKGROUND

Streptococcus pneumoniae is a leading cause of pneumonia, meningitis and sepsis in developing countries, particularly among children and HIV-infected persons. Pneumococcal oropharyngeal (OP) or nasopharyngeal (NP) colonization is a precursor to development of invasive disease. New conjugate vaccines hold promise for reducing colonization and disease.

METHODS

Prior to introduction of 10-valent pneumococcal conjugate vaccine (PCV10), we conducted a cross-sectional survey among HIV-infected parents of children <5 years old in rural Kenya. Other parents living with an HIV-infected adult were also enrolled. After broth enrichment, NP and OP swabs were cultured for pneumococcus. Serotypes were identified by Quellung. Antimicrobial susceptibility was performed using broth microdilution.

RESULTS

We enrolled 973 parents; 549 (56.4%) were HIV-infected, 153 (15.7%) were HIV-uninfected and 271 (27.9%) had unknown HIV status. Among HIV-infected parents, the median age was 32 years (range 15-74) and 374/549 (68%) were mothers. Pneumococci were isolated from 237/549 (43.2%) HIV-infected parents and 41/153 (26.8%) HIV-non-infected parents (p = 0.0003). Colonization with PCV10 serotypes was not significantly more frequent in HIV-infected (12.9%) than HIV-uninfected parents (11.8%; p = 0.70). Among HIV-infected parents, cooking site separate from sleeping area and CD4 count >250 were protective (OR = 0.6; 95% CI 0.4, 0.9 and OR = 0.5; 95% CI 0.2, 0.9, respectively); other associations were not identified. Among 309 isolates tested from all parents, 255 (80.4%) were penicillin non-susceptible (MIC ≥0.12 μg/ml).

CONCLUSIONS

Prevalence of pneumococcal colonization is high among HIV-infected parents in rural Kenya. If young children are the pneumococcal reservoir for this population, PCV10 introduction may reduce vaccine-type colonization and disease among HIV-infected parents through indirect protection.

摘要

背景

肺炎链球菌是发展中国家肺炎、脑膜炎和败血症的主要病因,尤其是在儿童和艾滋病毒感染者中。肺炎链球菌口咽部(OP)或鼻咽部(NP)定植是侵袭性疾病发生的先兆。新型结合疫苗有望减少定植和疾病发生。

方法

在引入10价肺炎球菌结合疫苗(PCV10)之前,我们在肯尼亚农村地区对5岁以下儿童的艾滋病毒感染父母进行了一项横断面调查。其他与艾滋病毒感染成年人共同生活的父母也被纳入研究。肉汤增菌后,对NP和OP拭子进行肺炎球菌培养。通过荚膜肿胀试验鉴定血清型。使用肉汤微量稀释法进行药敏试验。

结果

我们纳入了973名父母;549名(56.4%)为艾滋病毒感染者,153名(15.7%)为艾滋病毒未感染者,271名(27.9%)艾滋病毒感染状况未知。在艾滋病毒感染父母中,年龄中位数为32岁(范围15 - 74岁),374/549名(68%)为母亲。从237/549名(43.2%)艾滋病毒感染父母和41/153名(26.8%)艾滋病毒未感染父母中分离出肺炎球菌(p = 0.0003)。艾滋病毒感染父母中PCV10血清型定植的频率(12.9%)并不显著高于艾滋病毒未感染父母(11.8%;p = 0.70)。在艾滋病毒感染父母中,烹饪地点与睡眠区域分开以及CD4细胞计数>250具有保护作用(优势比分别为0.6;95%置信区间0.4,0.9和优势比为0.5;95%置信区间0.2,0.9);未发现其他关联。在所有父母检测的309株分离株中,255株(80.4%)对青霉素不敏感(最低抑菌浓度≥0.12μg/ml)。

结论

肯尼亚农村地区艾滋病毒感染父母中肺炎球菌定植的患病率很高。如果幼儿是该人群的肺炎球菌储存宿主,引入PCV10可能通过间接保护减少艾滋病毒感染父母中疫苗型定植和疾病的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adde/4715316/69fefae8bf4a/12879_2015_1312_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验